RADICAVA ORS

Serial Number 79298102
Registration 6422491
700

Registration Progress

Application Filed
Sep 15, 2020
Under Examination
Approved for Publication
May 4, 2021
Published for Opposition
May 4, 2021
Registered
Jul 20, 2021

Trademark Image

RADICAVA ORS

Basic Information

Serial Number
79298102
Registration Number
6422491
Filing Date
September 15, 2020
Registration Date
July 20, 2021
Published for Opposition
May 4, 2021
Drawing Code
4000

Status Summary

Current Status
Active
Status Code
700
Status Date
Jul 20, 2021
Registration
Registered
Classes
005

Rights Holder

Mitsubishi Tanabe Pharma Corporation

03
Address
3-2-10, Dosho-machi,
Chuo-ku, Osaka-shi Osaka 541-8505
JP

Ownership History

Mitsubishi Tanabe Pharma Corporation

Original Applicant
03
JP

Mitsubishi Tanabe Pharma Corporation

Owner at Publication
03
JP

Mitsubishi Tanabe Pharma Corporation

Original Registrant
03
JP

Legal Representation

Attorney
Jeffrey L. Costellia

USPTO Deadlines

Next Deadline
733 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2021-07-20)
Due Date
July 20, 2027
Grace Period Ends
January 20, 2028
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

24 events
Date Code Type Description Documents
Dec 6, 2021 FINO P FINAL DECISION TRANSACTION PROCESSED BY IB Loading...
Nov 17, 2021 FIMP P FINAL DISPOSITION PROCESSED Loading...
Nov 17, 2021 FICS P FINAL DISPOSITION NOTICE SENT TO IB Loading...
Oct 20, 2021 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Loading...
Jul 20, 2021 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
May 4, 2021 PUBO A PUBLISHED FOR OPPOSITION Loading...
May 4, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
May 3, 2021 GPNX P NOTIFICATION PROCESSED BY IB Loading...
Apr 14, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Apr 14, 2021 OP2R P NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Loading...
Apr 14, 2021 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Loading...
Apr 1, 2021 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Mar 25, 2021 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Mar 24, 2021 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Mar 24, 2021 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Mar 1, 2021 RFNT P REFUSAL PROCESSED BY IB Loading...
Feb 7, 2021 RFRR P REFUSAL PROCESSED BY MPU Loading...
Feb 7, 2021 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
Jan 29, 2021 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
Jan 28, 2021 DOCK D ASSIGNED TO EXAMINER Loading...
Jan 28, 2021 CNRT R NON-FINAL ACTION WRITTEN Loading...
Nov 24, 2020 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Nov 20, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Nov 19, 2020 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of central nervous system diseases; pharmaceutical preparations for protection against free radicals; pharmaceutical preparations for removing free radicals from human bodies; neuroprotective medicines; pharmaceutical preparations for the treatment of amyotrophic lateral sclerosis (ALS); pharmaceutical preparations for the treatment of acute ischemic stroke
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005